Αποτελέσματα Αναζήτησης
3 ημέρες πριν · Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of ...
- Adverum Biotechnologies (ADVM) Gets a Buy from TD Cowen
Adverum Biotechnologies has an analyst consensus of Strong...
- Adverum Biotechnologies (ADVM) Gets a Buy from TD Cowen
Get the latest Adverum Biotechnologies, Inc. (ADVM) stock news and headlines to help you in your trading and investing decisions.
2 ημέρες πριν · Adverum Biotechnologies has an analyst consensus of Strong Buy, with a price target consensus of $22.50. The company has a one-year high of $29.70 and a one-year low of $6.38. Currently, Adverum ...
16 Ιουλ 2024 · Graig Suvannavejh has given his Buy rating due to a combination of factors surrounding the promising prospects of Adverum Biotechnologies’ lead gene therapy, ixo-vec, for wet age-related macular...
6 ημέρες πριν · Should You Buy or Sell Adverum Biotechnologies Stock? Get The Latest ADVM Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
2 ημέρες πριν · REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for ...
Real time Adverum Biotechnologies (ADVM) stock price quote, stock graph, news & analysis.
